Vcanbio Cell & Gene Engineering Corp. Ltd. provided earnings guidance for the year 2018. The company will turn losses into gains in its net profit belonging to shareholders of the company in 2018 compared with the same period of the year before, with the net profit belonging to shareholders of the company to be between RMB 50 million and RMB 75 million. The net loss belonging to shareholders of the company after excluding extraordinary profit and loss will be between RMB 290 million and RMB 260 million.